Dr. Shanming Kuang is currently the Head of Center for Pharma Crystallization at Porton Shanghai and Senior Director of Solid Form Studies at J-Stat Research. Shanming obtained his PhD in physical chemistry from the Chinese University of Hong Kong. After a postdoc at Purdue University, Shanming spent more than 20 years in pharma industry with BMS, Roche, GSK, Crystal Pharmatech and J-Star Research Inc. His tenure involves managing solid state chemistry groups focusing on solid form screening and selection, crystallization process development and preformulation. His teams were integral in understanding drug candidate developability and ensuring projects were minimally impacted by solid-state property issues. Shanming has extensive experience in developability assessment for more than 400 small molecule drug candidates and has published more than 60 peered reviewed papers and patent applications.
: Combined In-Silico & Experimental Approach for Solid Form Screen & Selection